SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein

Human Molecular Genetics

Volumn 10, Issue 14, 2001, Pages 1441-1448

  Nakamura, Koichiro ^a   Jeong, Seon Yong ^b   Uchihara, Toshiki ^c   Anno, Midori ^d   Nagashima, Kazuo ^b,e   Nagashima, Toshiko ^f   Ikeda, Shu Ichi ^g   Tsuji, Shoji ^h   Kanazawa, Ichiro ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

^f TEINE KEIJINKAI HOSPITAL   (Japan)

^g SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GLUTAMINE; GUANINE; PEPTIDE ANTIBODY; POLYGLUTAMINE; PROTEIN ANTIBODY; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN;

ARTICLE; AUTOPSY; AUTOSOMAL DOMINANT INHERITANCE; BRAIN; CELL NUCLEUS INCLUSION BODY; CLINICAL ARTICLE; CONTROLLED STUDY; GENETICS; HUMAN; IMMUNOCYTOCHEMISTRY; JAPAN; MOLECULAR RECOGNITION; NERVE CELL; PEDIGREE; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION; STAINING; TRANSCRIPTION INITIATION; TRINUCLEOTIDE REPEAT;

ATAXIA;

EID: 0035393427     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.14.1441     Document Type: Article

References (35)

1. Phenotypic variability in autosomal dominant cerebellar ataxia type I is unrelated to genetic heterogeneity
2. Clinical features and classification of inherited ataxias
3. Autosomal dominant cerebellar ataxia: Phenotypic differences in genetically defined subtypes?
4. Glutamine repeats and neurodegenerative diseases: Molecular aspects
5. Transcriptional dysregulation in Huntington's disease
6. Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription
7. Identification of genes that modify ataxin-1-induced neurodegeneration
8. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1
9. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription
10. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity
11. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias
12. Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias
13. Analysis of polyglutamine-coding repeats in the TATA-binding protein in different human populations and in patients with schizophrenia and bipolar affective disorder
14. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: A new polyglutamine disease?
15. 'Cryptic' repeating triplets of purines and pyrimidines (cRRY(i)) are frequent and polymorphic: Analysis of coding cRRY(i) in the proopiomelanocortin (POMC) and TATA-binding protein (TBP) genes
16. Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: Triple-labeling immunofluorescent study
17. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human
18. Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6
19. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?
20. Intranuclear neuronal inclusions: A common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?
21. Cloning of a transcriptionally active human TATA binding factor
22. TBP-associated factors (TAFIIs): Multiple, selective transcriptional mediators in common complexes
23. Eukaryotic transcription factors
24. The N-terminal domain of the human TATA-binding protein plays a role in transcription from TATA-containing RNA polymerase II and III promoters
25. Effect of the non-conserved N-terminus on the DNA binding activity of the yeast TATA binding protein
26. The gene for the TATA binding protein (TBP) that contains a highly polymorphic protein coding CAG repeat maps to 6q27
27. No evidence for expanded polyglutamine sequences in bipolar disorder and schizophrenia
28. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
29. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
30. Fourteen and counting: Unraveling trinucleotide repeat diseases
31. Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin
32. Insoluble detergent-resistant aggregates form between pathological and non-pathological lengths of polyglutamine in mammalian cells
33. Amyloid formation by mutant huntingtin: Threshold, progressivity and recruitment of normal polyglutamine proteins
34. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation
35. Machado-Joseph disease gene product identified in lymphocytes and brain